Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
How to win the ovarian cancer stem cell battle: Destroying the roots
Akimasa Takahashi
, Linda Hong
, Ilana Chefetz
The Hormel Institute
Research output
:
Contribution to journal
›
Review article
›
peer-review
17
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'How to win the ovarian cancer stem cell battle: Destroying the roots'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Stem Cells
100%
Ovarian Cancer Stem Cells
100%
Ovarian Cancer
55%
Chemotherapy Resistance
33%
Chemotherapy
22%
Initial Treatment
22%
Disease Progression
11%
Clinical Trials
11%
Stem Disease
11%
Treatment Options
11%
Signaling Pathway
11%
Poor Prognosis
11%
Cancer Recurrence
11%
Cancer Treatment
11%
Conventional Chemotherapy
11%
Therapeutic Agents
11%
Cytoreductive Surgery
11%
Strategies to Overcome
11%
Recurrent Disease
11%
Current Therapeutics
11%
Therapeutic Regimen
11%
Cancer Stem Cell Markers
11%
Biological Properties
11%
Novel Targeted Therapy
11%
Marker-trait Association
11%
Excess Mortality
11%
Tumor Tissue
11%
Cancer Experience
11%
Signaling Cascades
11%
Cell-Associated
11%
Cell Surface Display
11%
Role in Cancer
11%
New Therapeutic Approaches
11%
Potential Inhibitors
11%
Cell Progression
11%
Anticancer Treatment
11%
Cell-targeted Therapy
11%
Cytoreductive Chemotherapy
11%
Gynecologic Malignancies
11%
Chemotherapy Cycles
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Ovary Cancer
100%
Chemotherapy Regimens
81%
Recurrent Disease
18%
Clinical Trial
9%
Disease Exacerbation
9%
Mortality Rate
9%
Cell Marker
9%
Cancer Recurrence
9%
Neoplasm
9%